IE
IRON icon

Israel Englander’s Disc Medicine IRON Stock Holding History

Israel Englander’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,000
Closed -$1.91M – 6029
2025
Q4 		$1.91M Buy
+24,000
New +$2.03M ﹤0.01% 3993
2024
Q2 		– Sell
-66,200
Closed -$4.12M – 6212
2024
Q1 		$4.12M Buy
+66,200
New +$4.29M ﹤0.01% 3069

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's IRON Position: Q2 2026 in Review

Israel Englander increased its Disc Medicine (IRON) stake by 28% in Q2 2026, buying an estimated $1.58M and bringing the position to 106,248 shares worth $7.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Israel Englander first reported a position in IRON in Q1 2021 and has held it in 17 quarters since. The position peaked at $14.7M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Israel Englander held 106,248 shares of Disc Medicine worth $7.77M as of Q2 2026.
  • Israel Englander bought 22,989 Disc Medicine shares in Q2 2026, an estimated $1.58M.
  • Disc Medicine made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2565 holding.
  • Israel Englander first reported a position in Disc Medicine in Q1 2021 and has held it in 17 quarters since.
  • Israel Englander's Disc Medicine position peaked at $14.7M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.